神州控股(00861) - 2019 - 年度财报

Financial Proceeds - As of December 31, 2018, the net proceeds from the rights issue conducted in September 2017 amounted to HKD 764 million, with HKD 571 million remaining for future investments[1] - Approximately HKD 198 million of the remaining proceeds has already been utilized, leaving HKD 373 million expected to be fully used by December 31, 2020[1] - All unutilized proceeds will be invested in healthcare big data projects or other identified suitable investment and acquisition opportunities[1]